Effects of diet on high-density lipoprotein cholesterol

Current Atherosclerosis Reports

Volumn 13, Issue 6, 2011, Pages 453-460

  Siri Tarino, Patty W ^a  

^a CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

Author keywords

Alcohol; Carbohydrate; Cholesterol efflux; Coronary heart disease; Diet; Dyslipidemia; Fat; Fish; HDL cholesterol; HDL C; Mediterranean diet; Monounsaturated fat; Obesity; Omega 3 fatty acids; Polyunsaturated fat; Saturated fat; Triglyceride; Weight loss

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OMEGA 3 FATTY ACID; TRIACYLGLYCEROL;

ALCOHOL CONSUMPTION; ARTICLE; CARBOHYDRATE ANALYSIS; CARDIOVASCULAR EFFECT; CARDIOVASCULAR RISK; DIETARY INTAKE; DISEASE ASSOCIATION; DISEASE MARKER; EXERCISE TEST; FOOD COMPOSITION; HUMAN; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; LOW CARBOHYDRATE DIET; MACRONUTRIENT; MEDITERRANEAN DIET; METABOLIC SYNDROME X; NUTRIENT CONTENT; THERAPY EFFECT; WEIGHT REDUCTION;

ALCOHOL DRINKING; CHOLESTEROL, HDL; CORONARY DISEASE; DIET; DIET, CARBOHYDRATE-RESTRICTED; DIET, MEDITERRANEAN; DIET, REDUCING; DIETARY FATS; FATTY ACIDS, OMEGA-3; HUMANS; METABOLIC SYNDROME X; RISK FACTORS; WEIGHT LOSS;

EID: 81155152282     PISSN: 15233804     EISSN: 15346242     Source Type: Journal    
DOI: 10.1007/s11883-011-0207-y     Document Type: Article

References (57)

1. GF Lewis DJ Rader 2005 New insights into the regulation of HDL metabolism and reverse cholesterol transport Circ Res 96 12 1221 1232 15976321 10.1161/01.RES.0000170946.56981.5c 1:CAS:528:DC%2BD2MXltlSjt7Y%3D (Pubitemid 40962099)
2. G Assmann AM Gotto Jr 2004 HDL cholesterol and protective factors in atherosclerosis Circulation 109 23 Suppl 1 III8-14 15198960
3. Medicine) IIo. Perspectives on biomarker and surrogate endpoint evaluation: Discussion forum summary. In: Medicine Io, editor. Washington, D.C.: The National Academies Press; 2011.
4. DJ Gordon BM Rifkind 1989 High-density lipoprotein-the clinical implications of recent studies N Engl J Med 321 19 1311 1316 2677733 10.1056/NEJM198911093211907 1:STN:280:DyaK3c%2FhsFSmsA%3D%3D (Pubitemid 19267219)
5. T Gordon WP Castelli MC Hjortland WB Kannel TR Dawber 1977 High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study Am J Med 62 5 707 714 193398 10.1016/0002-9343(77)90874-9 1:CAS:528:DyaE2sXhvVOhtbg%3D (Pubitemid 8110784)
6. MJ Stampfer FM Sacks S Salvini WC Willett CH Hennekens 1991 A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction N Engl J Med 325 6 373 381 2062328 10.1056/NEJM199108083250601 1:STN:280:DyaK3M3oslOntw%3D%3D
7. DR Jacobs Jr IL Mebane SI Bangdiwala MH Criqui HA Tyroler 1990 High density lipoprotein cholesterol as a predictor of cardiovascular disease mortality in men and women: the follow-up study of the Lipid Research Clinics Prevalence Study Am J Epidemiol 131 1 32 47 2293751 (Pubitemid 20014697)
8. DJ Gordon JL Probstfield RJ Garrison JD Neaton WP Castelli JD Knoke DR Jacobs Jr S Bangdiwala HA Tyroler 1989 High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies Circulation 79 1 8 15 2642759 10.1161/01.CIR.79.1.8 1:STN:280:DyaL1M%2FptVWjtg%3D%3D (Pubitemid 19043669)
9. D Weissglas-Volkov P Pajukanta 2010 Genetic causes of high and low serum HDL-cholesterol J Lipid Res 51 8 2032 2057 20421590 10.1194/jlr.R004739 1:CAS:528:DC%2BC3cXpvVOlur0%3D
10. HN Ginsberg 2000 Nonpharmacologic management of low levels of high-density lipoprotein cholesterol Am J Cardiol 86 12A 41L 45L 11374855 10.1016/S0002-9149(00)01469-7 1:CAS:528:DC%2BD3MXksVertg%3D%3D
11. M Briel I Ferreira-Gonzalez JJ You PJ Karanicolas EA Akl P Wu B Blechacz D Bassler X Wei A Sharman, et al. 2009 Association between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality: systematic review and meta-regression analysis BMJ 338 b92 19221140 10.1136/bmj.b92 This meta-analysis of 108 randomized trials with 299,310 patients showed no association of treatment-induced changes in HDL and risk of CHD events or death rates
12. •• http://www.nih.gov/news/health/may2011/nhlbi-26.htm This press release announces the early cessation of the Atherothrombosis Intervention in Metabolic Syndrome with Low HDL/High Triglycerides: Impact on Global Health(AIM-HIGH) randomized clinical trial, a study designed to evaluate the benefits of raising HDL cholesterol with niacin treatment in patients taking statins. No CHD benefit of the add-on therapy, which effectively increased HDL cholesterol and decreased triglyceride concentrations, was observed.
13. AV Khera M Cuchel M de la Llera-Moya A Rodrigues MF Burke K Jafri BC French JA Phillips ML Mucksavage RL Wilensky, et al. 2011 Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis N Engl J Med 364 2 127 135 21226578 10.1056/NEJMoa1001689 1:CAS:528:DC%2BC3MXmvFarsA%3D%3D This report identifies cholesterol efflux capacity as a relevant determinant of CHD risk and speaks to the relevance of HDL functionality over plasma concentrations
14. BF Asztalos M Tani EJ Schaefer 2011 Metabolic and functional relevance of HDL subspecies Curr Opin Lipidol 22 3 176 185 21537175 10.1097/MOL. 0b013e3283468061 1:CAS:528:DC%2BC3MXlvFGhs7k%3D This review provides an overview of the heterogeneity of HDL and its relevance to metabolism
15. SM Grundy 1999 Hypertriglyceridemia, insulin resistance, and the metabolic syndrome Am J Cardiol 83 9B 25F 29F 10357572 10.1016/S0002-9149(99) 00211-8 1:CAS:528:DyaK1MXjslektLo%3D (Pubitemid 29247378)
16. RM Krauss PW Siri 2004 Dyslipidemia in type 2 diabetes Med Clin North Am 88 4 897 909 15308384 10.1016/j.mcna.2004.04.004 1:CAS:528:DC%2BD2cXot1agu74%3D x (Pubitemid 39090344)
17. MA Austin MC King KM Vranizan RM Krauss 1990 Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk Circulation 82 2 495 506 2372896 10.1161/01.CIR.82.2.495 1:STN:280:DyaK3czit1GksA%3D%3D (Pubitemid 20257828)
18. ES Ford WH Giles WH Dietz 2002 Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey JAMA 287 3 356 359 11790215 10.1001/jama.287.3.356 (Pubitemid 34251969)
19. AD Mooradian MJ Haas KR Wehmeier NC Wong 2008 Obesity-related changes in high-density lipoprotein metabolism Obesity (Silver Spring) 16 6 1152 1160 10.1038/oby.2008.202 1:CAS:528:DC%2BD1cXmsFCgu70%3D (Pubitemid 351770500)
20. JD Browning JA Baker T Rogers J Davis S Satapati SC Burgess 2011 Short-term weight loss and hepatic triglyceride reduction: evidence of a metabolic advantage with dietary carbohydrate restriction Am J Clin Nutr 93 5 1048 1052 21367948 10.3945/ajcn.110.007674 1:CAS:528:DC%2BC3MXltlCqsbk%3D
21. AM Dattilo PM Kris-Etherton 1992 Effects of weight reduction on blood lipids and lipoproteins: a meta-analysis Am J Clin Nutr 56 2 320 328 1386186 1:CAS:528:DyaK38XlslSju7Y%3D
22. HI Katcher AM Hill JL Lanford JS Yoo PM Kris-Etherton 2009 Lifestyle approaches and dietary strategies to lower LDL-cholesterol and triglycerides and raise HDL-cholesterol Endocrinol Metab Clin North Am 38 1 45 78 19217512 10.1016/j.ecl.2008.11.010 1:CAS:528:DC%2BD1MXkt1eksrk%3D
23. S Rashid J Genest 2007 Effect of obesity on high-density lipoprotein metabolism Obesity (Silver Spring) 15 12 2875 2888 10.1038/oby.2007.342 1:CAS:528:DC%2BD1cXitVKgsro%3D (Pubitemid 351256646)
24. AS Leon OA Sanchez 2001 Response of blood lipids to exercise training alone or combined with dietary intervention Med Sci Sports Exerc 33 6 Suppl S502 515 11427777 1:CAS:528:DC%2BD3MXkslOhtL8%3D discussion S528-509
25. S Kodama S Tanaka K Saito M Shu Y Sone F Onitake E Suzuki H Shimano S Yamamoto K Kondo, et al. 2007 Effect of aerobic exercise training on serum levels of high-density lipoprotein cholesterol: a meta-analysis Arch Intern Med 167 10 999 1008 17533202 10.1001/archinte.167.10.999 1:CAS:528: DC%2BD2sXmvVGrtLk%3D (Pubitemid 46835787)
26. EJ Parks MK Hellerstein 2000 Carbohydrate-induced hypertriacylglycerolemia: historical perspective and review of biological mechanisms Am J Clin Nutr 71 2 412 433 10648253 1:CAS:528:DC%2BD3cXosFCnsQ%3D%3D (Pubitemid 30061218)
27. RM Krauss PJ Blanche RS Rawlings HS Fernstrom PT Williams 2006 Separate effects of reduced carbohydrate intake and weight loss on atherogenic dyslipidemia Am J Clin Nutr 83 5 1025 1031 16685042 1:CAS:528: DC%2BD28XkvFOrsLs%3D quiz 1205 (Pubitemid 44713100)
28. S Lewington G Whitlock R Clarke P Sherliker J Emberson J Halsey N Qizilbash R Peto R Collins 2007 Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths Lancet 370 9602 1829 1839 18061058 10.1016/S0140-6736(07)61778-4 (Pubitemid 350180032)
29. JS Volek MJ Sharman CE Forsythe 2005 Modification of lipoproteins by very low-carbohydrate diets J Nutr 135 6 1339 1342 15930434 1:CAS:528: DC%2BD2MXltFaiu78%3D (Pubitemid 40799592)
30. MJ Sharman WJ Kraemer DM Love NG Avery AL Gomez TP Scheett JS Volek 2002 A ketogenic diet favorably affects serum biomarkers for cardiovascular disease in normal-weight men J Nutr 132 7 1879 1885 12097663 1:CAS:528: DC%2BD38Xlt1egtLo%3D (Pubitemid 34742871)
31. JS Volek MJ Sharman AL Gomez TP Scheett WJ Kraemer 2003 An isoenergetic very low carbohydrate diet improves serum HDL cholesterol and triacylglycerol concentrations, the total cholesterol to HDL cholesterol ratio and postprandial pipemic responses compared with a low fat diet in normal weight, normolipidemic women J Nutr 133 9 2756 2761 12949361 1:CAS:528:DC%2BD3sXntlalu7o%3D (Pubitemid 37099756)
32. FB Hu 2010 Are refined carbohydrates worse than saturated fat? Am J Clin Nutr 91 6 1541 1542 20410095 10.3945/ajcn.2010.29622 1:CAS:528: DC%2BC3cXmslKktrc%3D
33. PW Siri-Tarino Q Sun FB Hu RM Krauss 2010 Saturated fat, carbohydrate, and cardiovascular disease Am J Clin Nutr 91 3 502 509 20089734 10.3945/ajcn.2008.26285 1:CAS:528:DC%2BC3cXisFyntL0%3D This review highlights advantages of carbohydrate restriction in the setting of obesity and insulin resistance
34. KL Stanhope JM Schwarz NL Keim SC Griffen AA Bremer JL Graham B Hatcher CL Cox A Dyachenko W Zhang, et al. 2009 Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans J Clin Invest 119 5 1322 1334 19381015 10.1172/JCI37385 1:CAS:528:DC%2BD1MXlsFyrtrg%3D
35. JA Welsh A Sharma JL Abramson V Vaccarino C Gillespie MB Vos 2010 Caloric sweetener consumption and dyslipidemia among US adults JAMA 303 15 1490 1497 20407058 10.1001/jama.2010.449 1:CAS:528:DC%2BC3cXltlCgsbc%3D This study documents significant inverse associations between consumption of added sugars and HDL cholesterol. As a cross-sectional study, however, its results require validation by interventional studies
36. JA Welsh A Sharma SA Cunningham MB Vos 2011 Consumption of added sugars and indicators of cardiovascular disease risk among US adolescents Circulation 123 3 249 257 21220734 10.1161/CIRCULATIONAHA.110.972166 1:CAS:528: DC%2BC3MXhtFequ70%3D
37. Astrup A, Dyerberg J, Elwood P, Hermansen K, Hu FB, Jakobsen MU, Kok FJ, Krauss RM, Lecerf JM, Legrand P, et al. The role of reducing intakes of saturated fat in the prevention of cardiovascular disease: where does the evidence stand in 2010? Am J Clin Nutr 2011.
38. S Liu WC Willett MJ Stampfer FB Hu M Franz L Sampson CH Hennekens JE Manson 2000 A prospective study of dietary glycemic load, carbohydrate intake, and risk of coronary heart disease in US women Am J Clin Nutr 71 6 1455 1461 10837285 1:CAS:528:DC%2BD3cXjvFGnsr0%3D (Pubitemid 30395891)
39. ES Ford S Liu 2001 Glycemic index and serum high-density lipoprotein cholesterol concentration among us adults Arch Intern Med 161 4 572 576 11252117 10.1001/archinte.161.4.572 1:STN:280:DC%2BD3M3jsVagtA%3D%3D (Pubitemid 32167523)
40. G Frost AA Leeds CJ Dore S Madeiros S Brading A Dornhorst 1999 Glycaemic index as a determinant of serum HDL-cholesterol concentration Lancet 353 9158 1045 1048 10199351 10.1016/S0140-6736(98)07164-5 1:STN:280:DyaK1M3htlCnsQ%3D%3D (Pubitemid 29149912)
41. Kelly S, Frost G, Whittaker V, Summerbell C. Low glycaemic index diets for coronary heart disease. Cochrane Database Syst Rev 2004(4):CD004467.
42. R Vrolix RP Mensink 2010 Effects of glycemic load on metabolic risk markers in subjects at increased risk of developing metabolic syndrome Am J Clin Nutr 92 2 366 374 20504977 10.3945/ajcn.2009.28339 1:CAS:528:DC%2BC3cXhtFWmsrbM
43. RP Mensink MB Katan 1992 Effect of dietary fatty acids on serum lipids and lipoproteins. A meta-analysis of 27 trials Arterioscler Thromb 12 8 911 919 1386252 10.1161/01.ATV.12.8.911 1:CAS:528:DyaK3sXjvVShsQ%3D%3D
44. RP Mensink PL Zock AD Kester MB Katan 2003 Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials Am J Clin Nutr 77 5 1146 1155 12716665 1:CAS:528:DC%2BD3sXntlamsb8%3D (Pubitemid 44858429)
45. SE Brien PE Ronksley BJ Turner KJ Mukamal WA Ghali 2011 Effect of alcohol consumption on biological markers associated with risk of coronary heart disease: systematic review and meta-analysis of interventional studies BMJ 342 d636 21343206 10.1136/bmj.d636 Alcohol consumption was associated with increased HDL cholesterol concentrations independent of other measured lipid parameters in this meta-analysis
46. EB Rimm P Williams K Fosher M Criqui MJ Stampfer 1999 Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors BMJ 319 7224 1523 1528 10591709 10.1136/bmj.319.7224.1523 1:CAS:528:DC%2BD3cXls1Kiuw%3D%3D
47. WS Harris 1997 n-3 fatty acids and serum lipoproteins: human studies Am J Clin Nutr 65 5 Suppl 1645S 1654S 9129504 1:CAS:528:DyaK2sXivFamu74%3D (Pubitemid 27187958)
48. EM Balk AH Lichtenstein M Chung B Kupelnick P Chew J Lau 2006 Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: a systematic review Atherosclerosis 189 1 19 30 16530201 10.1016/j. atherosclerosis.2006.02.012 1:CAS:528:DC%2BD28XhtVajsr3L (Pubitemid 44468073)
49. TA Mori V Burke IB Puddey GF Watts DN O'Neal JD Best LJ Beilin 2000 Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men Am J Clin Nutr 71 5 1085 1094 10799369 1:CAS:528:DC%2BD3cXivFymsL4%3D (Pubitemid 30230554)
50. YK Lungershausen M Abbey PJ Nestel PR Howe 1994 Reduction of blood pressure and plasma triglycerides by omega-3 fatty acids in treated hypertensives J Hypertens 12 9 1041 1045 7852747 10.1097/00004872-199409000- 00008 1:STN:280:DyaK2M7lsFOrug%3D%3D (Pubitemid 24294815)
51. EM Roth WS Harris 2010 Fish oil for primary and secondary prevention of coronary heart disease Curr Atheroscler Rep 12 1 66 72 20425273 10.1007/s11883-009-0079-6 1:CAS:528:DC%2BC3cXht1Cjs7nO
52. PR Kowey JA Reiffel KA Ellenbogen GV Naccarelli CM Pratt 2010 Efficacy and safety of prescription omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: a randomized controlled trial JAMA 304 21 2363 2372 21078810 10.1001/jama.2010.1735 1:CAS:528:DC%2BC3cXhsFWqs7nJ
53. M de Lorgeril P Salen JL Martin I Monjaud J Delaye N Mamelle 1999 Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study Circulation 99 6 779 785 9989963 (Pubitemid 29083018)
54. N Babio M Bullo J Salas-Salvado 2009 Mediterranean diet and metabolic syndrome: the evidence Public Health Nutr 12 9A 1607 1617 19689829 10.1017/S1368980009990449
55. K Esposito R Marfella M Ciotola C Di Palo F Giugliano G Giugliano M D'Armiento F D'Andrea D Giugliano 2004 Effect of a mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial JAMA 292 12 1440 1446 15383514 10.1001/jama.292.12. 1440 1:CAS:528:DC%2BD2cXnvFGisbY%3D (Pubitemid 39258336)
56. J Salas-Salvado J Fernandez-Ballart E Ros MA Martinez-Gonzalez M Fito R Estruch D Corella M Fiol E Gomez-Gracia F Aros, et al. 2008 Effect of a Mediterranean diet supplemented with nuts on metabolic syndrome status: one-year results of the PREDIMED randomized trial Arch Intern Med 168 22 2449 2458 19064829 10.1001/archinte.168.22.2449 1:CAS:528:DC%2BD1MXjvVOitA%3D%3D
57. CM Kastorini HJ Milionis K Esposito D Giugliano JA Goudevenos DB Panagiotakos 2011 The effect of Mediterranean diet on metabolic syndrome and its components: a meta-analysis of 50 studies and 534,906 individuals J Am Coll Cardiol 57 11 1299 1313 21392646 10.1016/j.jacc.2010.09.073 1:CAS:528: DC%2BC3MXkslOntLw%3D